Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1012 | 933 | 1012 | 988 | 1336 | 2331 |
Fund Return | 1.25% | -6.75% | 1.25% | -0.4% | 5.97% | 8.83% |
Place in category | 523 | 846 | 523 | 316 | 156 | 101 |
% in Category | 54 | 87 | 54 | 48 | 31 | 31 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global Technology Fund A DIST GBP | 42.11M | 18.73 | 11.59 | 20.94 | ||
Global Technology Fund W Acc GBP | 1.57B | 19.77 | 12.54 | 21.93 | ||
Global Multi Asset Income Fund I Ag | 17.32M | 5.94 | 1.27 | 5.45 | ||
EM Fund W Acc GBP | 22.9M | 7.21 | -6.44 | 5.33 | ||
European Dynamic Growth Fund W Acc | 19.26M | -2.36 | -1.40 | 9.61 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund U G | 4B | 5.16 | 5.09 | 10.55 | ||
Wellington Global Health Care EquiG | 2.07B | 6.70 | 4.03 | 11.14 | ||
Adamant Medtech I GBP | 1.67B | 10.76 | 0.98 | 12.16 | ||
Pharmaceuticals Index Trust R Acc | 17.34M | 2.83 | 1.59 | 8.80 | ||
Pharmaceuticals Index Trust R Dist | 119.05K | 2.80 | 1.61 | 8.80 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
UnitedHealth | US91324P1021 | 9.62 | 545.57 | +1.39% | |
Boston Scientific | US1011371077 | 7.60 | 103.04 | +0.32% | |
Novo Nordisk B | DK0062498333 | 5.93 | 603.7 | -0.66% | |
Stryker | US8636671013 | 5.58 | 390.43 | -0.16% | |
Eli Lilly | US5324571083 | 5.24 | 823.23 | +2.38% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review